Comparison of PCR mediated amplification of DNA and the classical methods for detection of Mycobacterium leprae in different types of clinical samples in leprosy patients and contacts

Leprosy Review

Volumn 74, Issue 1, 2003, Pages 18-30

  Torres, P ^a   Camarena, J J ^b   Gomez, J R ^a   Nogueira, J M ^b   Gimeno, V ^a   Navarro, J C ^b   Olmos, A ^b  

^a Sanatorio San Francisco de Borja   (Spain)

^b HOSPITAL UNIVERSITARIO DR PESET   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL DNA; BACTERIUM ANTIBODY; CLOFAZIMINE; DAPSONE; DNA FRAGMENT; LEPROMIN; RIFAMPICIN;

ARTICLE; BACTERIAL TRANSMISSION; BACTERIUM DETECTION; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; GENE AMPLIFICATION; GENETIC CODE; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFECTION RISK; LEPROMIN TEST; LEPROSY; MAJOR CLINICAL STUDY; MULTIBACILLARY LEPROSY; MYCOBACTERIUM LEPRAE; NONHUMAN; PAUCIBACILLARY LEPROSY; POLYMERASE CHAIN REACTION; PREVALENCE; SERODIAGNOSIS; STAINING; TUBERCULOSIS; ZOONOSIS;

ADULT; AGED; AGED, 80 AND OVER; BASE SEQUENCE; BIOPSY, NEEDLE; CARRIER STATE; CASE-CONTROL STUDIES; DNA, BACTERIAL; DRUG THERAPY, COMBINATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LEPROSTATIC AGENTS; LEPROSY; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MYCOBACTERIUM LEPRAE; POLYMERASE CHAIN REACTION; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; SPAIN;

EID: 0345700308     PISSN: 03057518     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Shepard CC, McRae DHA. A method for counting acid-fast bacteria. Int J Lepr, 1968; 36: 78-82.
2. Convit J, Aranzazu N, Ulrich M et al. Investigations related to the development of a leprosy vaccine. Int J Lepr, 1983; 51: 531-539.
3. Douglas JT, Steven LM, Fajardo T et al. The effects of chemotherapy on antibody levels in lepromatous patients. Lepr Rev 1988; 59: 127-135.
4. Ulrich M, Smith PG, Sampson C et al. IgM antibodies to native glycolipid-1 in contacts of leprosy patients in Venezuela: epidemiological observations and a prospective study of the risk of leprosy. Int J Lepr, 1991; 59: 405-415.
5. Soebono H, Klatser PR. A seroepidemiological study of leprosy in high-and low-endemic Indonesian villages. Int J Lepr, 1991; 59: 416-425.
6. De Wit MYL, Faber WR, Krieg SR et al. Application of a polymerase chain reaction for the detection of M. leprae in skin tissues. J Clin Microbiol, 1991; 29: 906-910.
7. Hartskeerl RA, De Wit MYL, Klatser PR. Polymerase chain reaction for the detection of M. leprae. J Gen Microbiol, 1989; 135: 2357-2364.
8. Williams DL, Gillis TP, Booth RJ et al. The use of a specific DNA probe and polymerase chain reaction for the detection of M. leprae. J Infect Dis, 1990; 162: 193-200.
9. Plikaytis BB, Gelber RH, Shinnick TM. Rapid and sensitive detection of M. leprae using a nested-primer gene amplification assay. J Clin Microbiol, 1990; 28: 1913-1917.
10. Woods SA, Cole ST. A rapid method for the detection of potentially viable M. leprae in human biopsies: a novel application of PCR. Fems Microb Lett, 1989; 65: 305-310.
11. Woods SA, Cole ST. A family of dispersed repeats in M. leprae. Mol Microbiol, 1990; 4: 1745-1751.
12. Job CK, Jayakurnar J, Williams DL, Gillis TP. Role of polymerase chain reaction in the diagnosis of early leprosy. Int J Lepr, 1997; 65: 461-463.
13. Klatser PR, van Beers S, Madjid B et al. Detection of M. leprae nasal carriers in populations for which leprosy is endemic. J Clin Microbiol, 1993; 31: 2947-2952.
14. Shepard CC. Acid-fast bacilli in nasal secretions in leprosy and results of inoculation of mice. Am J Hyg, 1966; 71: 147-157.
15. Fujiwara T, Hunter SW, Cho SN et al. Chemical synthesis and serology of the disaccharides and trisaccharides of phenolic glycolipid antigens from the leprosy bacillus and preparation of a disaccharide protein conjugate for serodiagnosis of leprosy. Infect Immun, 1984; 43: 245-252.
16. Cho SN, Yanaghara DL, Hunter SW et al. Serological specificity of phenolic glycolipid I from M. leprae and use in serodiagnosis of leprosy. Infect Immun, 1983; 41: 1077-1083.
17. Williams DL. PCR protocols. Laboratory Research Branch. GWL Hansen's Disease Center at Louisiana State University, 1990.
18. Ridley DS, Jopling WH. Classification of leprosy according to immunity; a five-group system. Int J Lepr, 1966; 34: 255-273.
19. WHO. Staining. Chapter 5. Histopathological examination and classification. Laboratory Techniques. WHO 1987, pp 37-40.
20. Moudgil KD, Mishra R, Talwar GP. Comparative evaluation of enzyme immunoassays based on synthetic glycoconjugates and phenolic glycolipid for immunodiagnosis of leprosy. Int J Lepr, 1990; 62: 60-64.
21. Brett SJ, Draper P, Payne SN, Rees RJW. Serological activity of a characteristic phenolic glycolipid from M. leprae in sera from patients with leprosy and tuberculosis. Clin Exp Immunol, 1983; 52: 271-279.
22. Bach MA, Wallach D, Flaguel B et al. Antibodies to phenolic glycolipid 1 and to whole M. leprae in leprosy patients: evolution during therapy. Int J Lepr, 1986; 54: 256-267.
23. WHO. Report of the Second Coordinating Meeting on Implementation of Multidrug Therapy in Leprosy Control Programmes. WHO, Geneva, 1987, WHO/CDS/LEP/87·2.
24. Santos AR, De Miranda AB, Sarno EN et al. Use of PCR-mediated amplification of M. leprae DNA in different types of clinical samples for the diagnosis of leprosy. J Med Microbiol, 1993; 39: 298-304.
25. Rafi A, Donoghue HD, Stanford JL. Application of polymerase chain reaction for the detection of M. leprae DNA in specimens from treated leprosy patients. Int J Lepr, 1995; 63: 42-47.
26. Jamil S, Keer JT, Lucas SB et al. Use of polymerase chain reaction to assess effciacy of leprosy chemotherapy. Lancet, 1993; 342: 264-268.
27. Constant-Desportes M, Guelpa-Lauras C, Carolina J et al. A case of relapse with drug susceptible M. leprae after multidrug therapy. Int J Lepr, 1991; 59: 242-247.
28. WHO Study Group. Chemotherapy of leprosy for control programmes. WHO, Geneva, 1982, Tech Rep. Ser. 675.
29. Williams DL, Gillis TP, Fiallo P et al. Detection of M. leprae and the potential for monitoring antileprosy drug therapy directly from skin biopsies by PCR. Mol Cell Probes, 1992; 6: 401-410.
30. Kampirapap K, Singtham N, Klatser PR, Wiriyawipart S. DNA amplification for detection of leprosy and assessment of efficacy of leprosy chemotherapy. Int J Lepr, 1998; 66: 16-21.
31. Gupte MD. Research needs related to epidemiology and control: Subclinical infection. Int J Lepr, 1996; 64: 529-533.
32. Pallen MJ, McDermott RD. How might M. leprae enter the body? Lepr Rev, 1986; 57: 289-297.
33. De Wit MYL, Faber WR, Krieg JT et al. Application of a polymerase chain reaction for the detection of M. leprae in skin tissues. J Clin Microbiol, 1991; 29: 906-910.
34. Bagshawe AF, Garsia RJ, Baumgart K, Astbury L. IgM serum antibodies to phenolic glycolipid-1 and clinical leprosy: two years observation in a community with hyperendemic leprosy. Int J Lepr, 1990; 58: 25-30.
35. Nordeen SKL. The epidemiology of leprosy. In: Hastings R (ed) Leprosy, 1st edn. Churchill Livingstone, Edinburgh, 1985, pp 15-30.
36. Van Beers S, Izumi S, Madjid B et al. An epidemiological study of leprosy infection by serology and polymerase chain reaction. Int J Lepr, 1994; 62: 1-9.
37. Milep2 Study Group. Approaches to studying the transmission of M. leprae. Lepr Rev 2000; 26: S26-S32.
38. Dharmendra, Chaterjee KR. Prognostic value of lepromin test in contacts of leprosy cases. Lepr Ind, 1955; 27: 149-152.
39. Dockrell HM, Young S, MacFarlane A et al. Possible transmission of M. leprae in a group of UK leprosy contacts. Lancet, 1991; 338: 739-743.
40. Tin K. Population screening and chemoprophylaxis for household contacts of leprosy patients in the Republic of the Marshall Islands. Int J Lepr, 1999; 67: S16-S18.